Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: Development and evaluation of a simple, standard protocol

Journal of Clinical Microbiology

Volumn 53, Issue 4, 2015, Pages 1324-1330

  Lau, Anna F ^a   Kabir, Masrura ^a   Chen, Sharon C A ^a,b   Playford, E Geoffrey ^c   Marriott, Deborah J ^d   Jones, Michael ^e   Lipman, Jeffrey ^f   McBryde, Emma ^g   Gottlieb, Thomas ^h   Cheung, Winston ^h   Seppelt, Ian ⁱ   Iredell, Jonathan ^a,j   Sorrell, Tania C ^a,j  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h Department of Microbiology and Infectious Diseases   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j University of Sydney   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; FLUCONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; COHORT ANALYSIS; CRITICALLY ILL PATIENT; FUNGAL COLONIZATION; FUNGAL DETECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; NONHUMAN; PERINEUM; PICHIA KUDRIAVZEVII; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROAT; URINALYSIS; CANDIDA; CANDIDIASIS, INVASIVE; CRITICAL ILLNESS; DIAGNOSTIC TEST; EVALUATION STUDY; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHARYNX; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; STANDARDS; URINE;

CANDIDA; CANDIDA GLABRATA;

CANDIDA; CANDIDIASIS, INVASIVE; CARRIER STATE; CRITICAL ILLNESS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; INTENSIVE CARE UNITS; MICROBIOLOGICAL TECHNIQUES; PERINEUM; PHARYNX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URINE;

EID: 84925271420     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03239-14     Document Type: Article

References (38)

1. Vazquez JA. 2010. Invasive fungal infections in the intensive care unit. Semin Respir Crit Care Med 31:79-86. http://dx.doi.org/10.1055/s-0029-1246289.
2. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O. 2009. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37:1612-1618. http://dx.doi.org/10.1097/CCM.0b013e31819efac0.
3. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25-31. http://dx.doi.org/10.1086/504810.
4. Morrell M, Fraser VJ, Kollef MH. 2005. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640-3645. http://dx.doi.org/10.1128/AAC.49.9.3640-3645.2005.
5. Cruciani M, de Lalla F, Mengoli C. 2005. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 31:1479-1487. http://dx.doi.org/10.1007/s00134-005-2794-y.
6. Playford EG, Webster AC, Sorrell TC, Craig JC. 2006. Antifungal agents for preventing fungal infections in nonneutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 57:628-638. http://dx.doi.org/10.1093/jac/dki491.
7. Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH. 2005. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 33:1928-1935; quiz, 1936. http://dx.doi.org/10.1097/01.CCM.0000178352.14703.49.
8. Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. 2006. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 34:1216-1224. http://dx.doi.org/10.1097/01.CCM.0000208357.05675.C3.
9. Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Ja'alam K, Huang S, Nangia V, Kurup A, Padiglione AA. 2009. Consensus statement on the management of invasive candidiasis in intensive care units in the Asia-Pacific region. Int J Antimicrob Agents 34:205-209. http://dx.doi.org/10.1016/j.ijantimicag.2009.03.014.
10. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH. 2007. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26:271-276. http://dx.doi.org/10.1007/s10096-007-0270-z.
11. Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts JM. 2003. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31:752-757. http://dx.doi.org/10.1097/01.CCM.0000053525.49267.77.
12. Paphitou NI, Ostrosky-Zeichner L, Rex JH. 2005. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 43:235-243. http://dx.doi.org/10.1080/13693780410001731619.
13. Ibàñez-Nolla J, Nolla-Salas M, León MA, García F, Marrugat J, Soria G, Díaz RM, Torres-Rodríguez JM. 2004. Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 48:181-192. http://dx.doi.org/10.1016/S0163-4453(03)00120-8.
14. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. 1994. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758. http://dx.doi.org/10.1097/00000658-199412000-00008.
15. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA; EPCAN Study Group. 2006. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730-737. http://dx.doi.org/10.1097/01.CCM.0000202208.37364.7D.
16. León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, Cava Study Group. 2009. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624-1633. http://dx.doi.org/10.1097/CCM.0b013e31819daa14.
17. Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC. 2009. Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 35: 2141-2145. http://dx.doi.org/10.1007/s00134-009-1619-9.
18. Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, Cornely OA, Patino H, Black TA. 28 September 2009. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.01031-09.
19. Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C; EPCAN Study Group. 2007. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 50:302-310. http://dx.doi.org/10.1111/j.1439-0507.2007.01366.x.
20. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Hammond JM, Hendrix CW. 2000. The diagnostic value of fungal surveillance cultures in critically ill patients. Surg Infect (Larchmt) 1:273-281. http://dx.doi.org/10.1089/109629600750067200.
21. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B. 2005. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31:393-400. http://dx.doi.org/10.1007/s00134-005-2571-y.
22. León C, Alvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jordá R, Saavedra P, Palomar M, EPCAN Study Group. 2009. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 28:233-242. http://dx.doi.org/10.1007/s10096-008-0618-z.
23. Magill SS, Swoboda SM, Johnson EA, Merz WG, Pelz RK, Lipsett PA, Hendrix CW. 2006. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis 55:293-301. http://dx.doi.org/10.1016/j.diagmicrobio.2006.03.013.
24. Magill SS, Swoboda SM, Shields CE, Colantuoni EA, Fothergill AW, Merz WG, Lipsett PA, Hendrix CW. 2009. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Ann Surg 249:657-665. http://dx.doi.org/10.1097/SLA.0b013e31819ed914.
25. Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A. 2004. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443-2449. http://dx.doi.org/10.1097/01.CCM.0000147726.62304.7F.
26. Van Horn KG, Audette CD, Tucker KA, Sebeck D. 2008. Comparison of 3 swab transport systems for direct release and recovery of aerobic and anaerobic bacteria. Diagn Microbiol Infect Dis 62:471-473. http://dx.doi.org/10.1016/j.diagmicrobio.2008.08.004.
27. Van Horn KG, Audette CD, Sebeck D, Tucker KA. 2008. Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability. J Clin Microbiol 46:1655-1658. http://dx.doi.org/10.1128/JCM.02047-07.
28. Lau A, Sorrell TC, Chen S, Stanley K, Iredell J, Halliday C. 2008. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol 46:3021-3027. http://dx.doi.org/10.1128/JCM.00689-08.
29. Lau A, Sorrell TC, Lee O, Stanley K, Halliday C. 2008. Colony multiplex-tandem PCR for rapid, accurate identification of fungal cultures. J Clin Microbiol 46:4058-4060. http://dx.doi.org/10.1128/JCM.01411-08.
30. Lau A, Halliday C, Chen SCA, Playford EG, Stanley K, Sorrell TC. 2010. Comparison of whole blood, serum and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 48:811-816. http://dx.doi.org/10.1128/JCM.01650-09.
31. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. 1988. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 26:429-432.
32. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. 1989. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149:2349-2353.
33. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. 2002. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708-1717. http://dx.doi.org/10.1007/s00134-002-1540-y.
34. Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C. 2008. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 40:145-153. http://dx.doi.org/10.1080/00365540701534509.
35. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163. http://dx.doi.org/10.1128/CMR.00029-06.
36. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21. http://dx.doi.org/10.1186/1471-2334-6-21.
37. Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. 2007. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Mycoses 50:52-57. http://dx.doi.org/10.1111/j.1439-0507.2006.01309.x.
38. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48:1695-1703. http://dx.doi.org/10.1086/599039.